These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 36359789)

  • 61. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy.
    Honigberg LA; Smith AM; Sirisawad M; Verner E; Loury D; Chang B; Li S; Pan Z; Thamm DH; Miller RA; Buggy JJ
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13075-80. PubMed ID: 20615965
    [TBL] [Abstract][Full Text] [Related]  

  • 62. B cell TLRs and induction of immunoglobulin class-switch DNA recombination.
    Pone EJ; Xu Z; White CA; Zan H; Casali P
    Front Biosci (Landmark Ed); 2012 Jun; 17(7):2594-615. PubMed ID: 22652800
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
    He B; Qiao X; Cerutti A
    J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Endogenous antigen tunes the responsiveness of naive B cells but not T cells.
    Zikherman J; Parameswaran R; Weiss A
    Nature; 2012 Sep; 489(7414):160-4. PubMed ID: 22902503
    [TBL] [Abstract][Full Text] [Related]  

  • 65. B-cell receptor signal strength influences terminal differentiation.
    Lechouane F; Bonaud A; Delpy L; Casola S; Oruc Z; Chemin G; Cogné M; Sirac C
    Eur J Immunol; 2013 Mar; 43(3):619-28. PubMed ID: 23280426
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
    Tedder TF; Poe JC; Haas KM
    Adv Immunol; 2005; 88():1-50. PubMed ID: 16227086
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Caveolin-1: The Unnoticed Player in TCR and BCR Signaling.
    Fiala GJ; Minguet S
    Adv Immunol; 2018; 137():83-133. PubMed ID: 29455848
    [TBL] [Abstract][Full Text] [Related]  

  • 68. B cell autonomous TLR signaling and autoimmunity.
    Meyer-Bahlburg A; Rawlings DJ
    Autoimmun Rev; 2008 Feb; 7(4):313-6. PubMed ID: 18295736
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Toll-Like Receptor Pathways in Autoimmune Diseases.
    Chen JQ; Szodoray P; Zeher M
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):1-17. PubMed ID: 25687121
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
    Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
    J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus.
    Malkiel S; Barlev AN; Atisha-Fregoso Y; Suurmond J; Diamond B
    Front Immunol; 2018; 9():427. PubMed ID: 29556239
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nucleic acid recognition receptors in autoimmunity.
    Krug A
    Handb Exp Pharmacol; 2008; (183):129-51. PubMed ID: 18071658
    [TBL] [Abstract][Full Text] [Related]  

  • 73. TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells.
    Suthers AN; Sarantopoulos S
    Front Immunol; 2017; 8():775. PubMed ID: 28751890
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
    Nitschke L
    Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Integrin CD11b Negatively Regulates B Cell Receptor Signaling to Shape Humoral Response during Immunization and Autoimmunity.
    Zhou M; Dascani P; Ding C; Kos JT; Tieri D; Lin X; Caster D; Powell D; Wen C; Watson CT; Yan J
    J Immunol; 2021 Oct; 207(7):1785-1797. PubMed ID: 34470858
    [TBL] [Abstract][Full Text] [Related]  

  • 76. B cell receptor and Toll-like receptor signaling coordinate to control distinct B-1 responses to both self and the microbiota.
    Kreuk LS; Koch MA; Slayden LC; Lind NA; Chu S; Savage HP; Kantor AB; Baumgarth N; Barton GM
    Elife; 2019 Aug; 8():. PubMed ID: 31433298
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Innate pathways to B-cell activation and tolerance.
    Crampton SP; Voynova E; Bolland S
    Ann N Y Acad Sci; 2010 Jan; 1183():58-68. PubMed ID: 20146708
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.
    Pollard KM; Escalante GM; Huang H; Haraldsson KM; Hultman P; Christy JM; Pawar RD; Mayeux JM; Gonzalez-Quintial R; Baccala R; Beutler B; Theofilopoulos AN; Kono DH
    J Immunol; 2017 Dec; 199(11):3739-3747. PubMed ID: 29055005
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CD19 and CD32b differentially regulate human B cell responsiveness.
    Karnell JL; Dimasi N; Karnell FG; Fleming R; Kuta E; Wilson M; Wu H; Gao C; Herbst R; Ettinger R
    J Immunol; 2014 Feb; 192(4):1480-90. PubMed ID: 24442430
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway.
    Schweighoffer E; Vanes L; Nys J; Cantrell D; McCleary S; Smithers N; Tybulewicz VL
    Immunity; 2013 Mar; 38(3):475-88. PubMed ID: 23453634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.